Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study - sprookjes - yvandenbroek - TriplyDB

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study

http://www.wikidata.org/entity/Q35151053

about

Stromal Targets for Fluorescent-Guided Oncologic Surgery Urokinase receptor and resistance to targeted anticancer agents Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis.uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery (68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2 Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.Human mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture models

P2860

Q26774497-04679F19-ABA5-4049-9976-4531AA726521 Q26797385-9D625667-368D-427F-BFB1-DE25823BECD3 Q28077999-036C9E65-5A04-4458-A855-65906BFD350A Q33703133-EDD581F0-C8D2-49D4-9D14-5F0ED91FDEA4 Q33709060-66521B2B-5AC2-46DD-8FB4-C8E34E93593C Q35097486-8A992D94-A01C-4E0C-AFCD-7017E7121D97 Q35781008-17B57DCC-0EFC-4FEF-AE2C-304EC28CA14E Q35987322-6BB41E6B-F461-4F50-9D13-589389DE38BA Q36568335-F43D2AA4-FCA9-4BF2-ADD9-1A7ACCC9F60C Q38555225-1213C89E-427A-4072-ADED-31E8C1D79F0A Q38692304-926C0926-8A51-4E0C-89FF-A36748B52C6D Q39424309-11833006-11F1-40AC-B395-43DECD3EBB69 Q41542151-3ED7F6CA-D788-4E10-9126-61EF298A3B80 Q58129602-C9B448C9-45BC-4DC1-B95A-CB85BCE39C9E

P2860

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study

http://www.wikidata.org/entity/Q35151053

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@ast

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@en

type

label

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@ast

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@en

prefLabel

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@ast

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@en

P1433

Q35151053-8140C3CB-0810-4BA8-BA12-24955D3D5114

P1476

Q35151053-231DF29B-5AC8-42E6-8933-094CD38FCFBA

P2093

Q35151053-4E5F8595-F3FE-4D46-AACD-EA6B07236158

Q35151053-52988DDD-3D5A-45B1-A9EC-CAA912FCBD08

Q35151053-73DFE25B-73B8-4DEA-B2F2-3CBCE1D56276

Q35151053-D04A790B-303A-471B-A9B6-67512185601B

Q35151053-D5053ED6-A009-483A-86C9-93A3083B1EDF

Q35151053-EEB90ED7-82BB-4EF8-9BE4-BCFA995E638D

P2860

Q35151053-03418E4E-467B-4288-A39D-455B7051E43B

Q35151053-04FBAFE0-FEF1-45E3-B2DB-9D9C36D20702

Q35151053-05A19A14-B5B5-4C51-A255-8A012DD43906

Q35151053-0BB08AA0-5ED7-456B-A2B3-58995BF5275D

Q35151053-23734B64-599E-4096-81E3-56A194878798

Q35151053-46C71D4E-38F6-46C9-934B-67127C52F7ED

Q35151053-52681557-37C7-4C48-8F79-F94BF0FA2222

Q35151053-6C2B8394-14EE-463D-8971-AC887CA6B3EC

Q35151053-720F17A6-88DE-400C-9DAB-0F899660FD21

Q35151053-9436E97A-2BAC-4807-B5AA-D34122F120B6

P2888

Q35151053-2B75F68D-9579-4F4C-9AFE-8EB7C9C545C4

P304

Q35151053-7B478D17-4061-4548-B9F0-405583790E2D

P31

Q35151053-DEFEEA60-6EE2-4C0E-AC1C-E104D607E6E6

P356

Q35151053-E3F74CEA-EB12-4358-BAEA-00D5F8B9CFF5

P407

Q35151053-73E03C72-6C4A-4BCD-8630-98C56D7A1459

P478

Q35151053-845B67A4-6A6A-40AA-9951-E0EFBFB88698

P50

Q35151053-53E65CB9-99AF-45BE-AD1B-1AC0DBAE9253

Q35151053-546A96EB-EAC9-4397-93FB-E6FA84860233

P577

Q35151053-14C73D72-A19A-4241-BB3C-7331FB3E9A0D

P5875

Q35151053-116D33D1-BE4A-4971-AFCA-29258A7C0E16

P6179

Q35151053-B3C31DA3-05ED-4716-B05F-65008F4EFF44

P698

Q35151053-FCD2C0B0-222E-4178-9DAA-93C448E83E82

P921

Q35151053-8C179581-9C6E-42AA-B1A6-05942F426FCD

Q35151053-F843E9BA-83A8-4065-B962-0D6CEE08227C

P932

Q35151053-7A2E33F7-1D6E-4B07-9077-C102D11535CD

P356

1471-2407-14-269

P1433

P1476

Expression of uPAR in tumor-as ...... patient prognosis: a TMA study

@en

P2093

Alexander L Vahrmeijer

http://www.w3.org/2001/XMLSchema#string

Andrew P Mazar

http://www.w3.org/2001/XMLSchema#string

Cornelis J H van de Velde

http://www.w3.org/2001/XMLSchema#string

Floris P R Verbeek

http://www.w3.org/2001/XMLSchema#string

Hendrica A J M Prevoo

http://www.w3.org/2001/XMLSchema#string

Martin C Boonstra

http://www.w3.org/2001/XMLSchema#string

P2860

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

The role of the myofibroblast in tumor stroma remodeling

Structure of human urokinase plasminogen activator in complex with its receptor

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.

Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.

Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Stromal myofibroblasts are drivers of invasive cancer growth.

P2888

1471-2407-14-269

P304

269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-269

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Cornelis F.M. Sier

P577

2014-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261755229

http://www.w3.org/2001/XMLSchema#string

P6179

1030066314

http://www.w3.org/2001/XMLSchema#string

P698

24742002

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3997436

http://www.w3.org/2001/XMLSchema#string